When was Manus Bio founded?

Manus Bio was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Manus Bio located?

Manus Bio is headquartered in Cambridge, United States.

Who is the current CEO of Manus Bio?

Ajikumar Parayil and Jason Whaley s of Manus Bio. Ajikumar Parayil has also founded 1 company.

How many employees does Manus Bio have?

As of Apr 30, 2026, the latest employee count at Manus Bio is 175.

Is Manus Bio a funded company?

Manus Bio is a funded company, having raised a total of $125M across 18 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2012.

When was the latest funding round of Manus Bio?

Manus Bio's latest funding was a $***** Series B round on May 31, 2023, with participation from 0 investor.

Where does Manus Bio rank among its competitors?

Manus Bio ranks 1st amongst 54 active competitors, of which 23 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Zymochem, which secured $21M in Jan, 2024.

Who are the top competitors of Manus Bio?

Manus Bio's top competitors include Zymochem, Biotia and Kallyope. Among them, Zymochem secured the most recent funding round in January, 2024.

Manus Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of phytochemicals using microbial fermentation. It produces sustainable eco-friendly products using natural resources for our daily life needs. They recreate natural processes in the microorganism. It converts carbon and plant-derived substrates to produce natural ingredients, with applications as flavours, fragrance, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals.

Website: www.manusbio.com/
Social
Email ID: *****@manusbio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2011

Location

Cambridge, United States

Stage

Series B

Total Funding

$125M in 18 rounds

Latest Funding Round

Series B, May 31, 2023, $*****

Investors

Nelstone Ventures & 18 more

Ranked

1^st among 54 active competitors

Employee Count

175 as on Apr 30, 2026

Similar Companies

Zymochem & 63 more

View Manus Bio's full profile

Manus Bio has raised a total funding of $125M over 18 rounds. Its first funding round was on Jan 01, 2012. Manus Bio has 19 institutional investors.

Here is the list of recent funding rounds of Manus Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 31, 2023	4361828	Series B	5428853	7418198	1921659	1271369
Sep 01, 2022	5309290	Grant (prize money)	8931218	5765266	6667102	Gates
Nov 06, 2020	5683555	Series B	2967504	7216031	BBGI	1107965

Access funding benchmarks and valuations. Sign up today!

View details of Manus Bio's funding rounds and investors

The founders of Manus Bio are Christopher Pirie, Gregory Stephanopoulos and Ajikumar Parayil. Ajikumar Parayil is the CEO of Manus Bio.

Here are the details of Manus Bio's key team members:

Christopher Pirie: Former Co-Founder of Manus Bio and founder of 2 other companies, Virvio and .
Gregory Stephanopoulos: Co-Founder of Manus Bio.
Contact Info: 1 email address
Ajikumar Parayil: Founder and CEO of Manus Bio.
Jason Whaley: CEO of Manus Bio.

View details of Manus Bio's Founder profiles and Board Members

Manus Bio's employee count trend

Manus Bio has 175 employees as of Apr 26. Here is Manus Bio's employee count trend over the years:

Uncover Manus Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Manus Bio include Zymochem, Biotia and Kallyope. Here is the list of Top 10 competitors of Manus Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manus Bio 2011, Cambridge (United States), Series B	Developer of phytochemicals using microbial fermentation	$125M	Energy Impact Partners, Nelstone Ventures ... & 17 others	52/100
2nd	Zymochem 2014, Berkeley (United States), Series A	Provider of engineered microbes and biosynthetic pathways for industrial chemicals	$25.4M	Breakout Ventures, Litani Ventures & 12 others	60/100
3rd	Biotia 2016, Brooklyn (United States), Series A	Provider of sequencing-based solutions for hospitals	$10.4M	Leawood Venture Capital, OCA Ventures & 16 others	59/100
4th	Kallyope 2014, New York City (United States), Series D	Discovering novel therapeutics for neurological and metabolic diseases	$479M	The Column Group, Lux Capital & 21 others	58/100
5th	Photanol 2008, Amsterdam (Netherlands), Series A	Provider of technology for light-powered bio-production of chemicals	$9.3M	UvA Ventures Holding, EIC Fund & 3 others	53/100
6th	BioCorteX 2021, London (United Kingdom), Seed	Developer of human-microbiome platform for drug development	$5M	Sofinnova Partners, Hoxton Ventures & 1 others	52/100
7th	MicroByre 2017, San Francisco (United States), Seed	Developer of genetically engineered strains of microorganisms	$7.67M	Planetary Technologies, Climate Capital & 6 others	47/100
8th	MicroGen Diagnostics 2011, Orlando (United States), Seed	Provider of sequencing and molecular diagnostic services	$1.65M	-	43/100
9th	Kaleido Biosciences 2015, Cambridge (United States), Deadpooled	Developer of microbiome metabolic therapies for inflammatory conditions	$165M	Rock Springs Capital, Invus & 7 others	43/100
10th	Perseus Biomics 2020, Tienen (Belgium), Funding Raised	Provider of microbiome analysis technology for delivering precise microbiome profiles	-	EIC Fund, Europa & 1 others	40/100